NR4A1 and cancer: Moreover, a significantly higher risk was found for hormone receptor-negative cancers than hormone receptor-positive ones: for women <65 years, HR=2.31 (95% CI, 1.76-3.02); for women ≥65, HR=2.59 (95% CI, 1.82-3.70).